Skip to main content
. 2021 Nov 5;8:760140. doi: 10.3389/fcvm.2021.760140

Table 1.

Category of applications of HHGE and the recommendation from International Commission on the Clinical Use of Human Germline Genome Editing.

Category Definition Characteristics Recommendation
A Serious monogenic Diseases
Heritability: 100%
◆ Autosomal dominant disease (one parent carries affected homozygote)
◆ Autosomal recessive disease (both parents carry affected homozygotes)
◆ X-linked recessive diseases (female parent carries affected homozygote, male parent carries affected hemizygote)
All is suitable for HHGE
B Serious monogenic Diseases
Heritability: 25–50%
◆ Autosomal dominant disease (one parent carries affected heterozygote)
◆ Autosomal recessive disease (both parents carry affected heterozygotes)
◆ X-linked dominant disease (female parent carries affected heterozygote)
◆ X-linked recessive diseases (female parent carries affected heterozygote, male parent carries affected hemizygote)
A small subset is suitable for HHGE
C Mild monogenic diseases Mainly affecting quality of life;
Could be mitigated by medical or lifestyle interventions
e.g., familial hypercholesterolemia
Unsuitable for HHGE, because the balance of risks and benefits is unknown
D Polygenic diseases Disease were caused by a large number of genetic variants
e.g., T2DM
E Other applications Enhancing human ability, or obtaining new function
F Monogenic conditions that cause infertility Treating e infertility caused by monogenic variant in germline cell

HHGE, Heritable Human Genome Editing.